Charity Number: 1134935 Company No: 07087270
## **JNETICS**
(Limited by Guarantee)
**FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
Internal Use#
## **Jnetics**
**Contents of the Financial Statements** _for the year ended 31 December 2021_
||Page|
|---|---|
|Reference and Administrative Details|3|
|Report of the Directors|4 - 6|
|Report of the Independent Examiner|7|
|Statement of Financial Activities|8|
|Statement of Financial Position|9|
|Notes to the Financial Statements|10 - 15|
Internal Use#
## **Jnetics**
**Reference and Administrative Details** _for the year ended 31 December 2021_
## **Directors/Trustees**
AL Angel L Birnbaum (appointed 18 May 2022) L Blitz (appointed 1 June 2021) N Goldschneider (appointed 3 March 2021) J Harris E Kerr (resigned 1 May 2021) AM Leon (appointed 21 October 2021) IBP Pearl (resigned 21 October 2021) Dr TM Rothenberg (resigned 1 May 2021)
## **Registered Office**
Unit 207 Balfour House 741 High Road Finchley London N12 0BP
## **Registered Number**
07087270
**English Charity Number** 1134935
## **Independent Examiner**
Oliver Clive & Co Limited Chartered Accountants 14 David Mews London W1U 6EQ
## **Bankers**
Barclays Bank UK PLC 1 Churchill Place London E14 5HP England
3
Internal Use#
## **Jnetics**
## **Report of the Directors** _for the year ended 31 December 2021_
The directors are pleased to present their report together with the financial statements for the year ended 31 December 2021.
## **Principal Activities and Charitable Objectives**
Jnetics is a charity established for the following purposes:
• To increase awareness and understanding of Jewish genetic disorders (JGDs) among affected families, patient groups, healthcare professionals, and the Jewish and wider community.
• To improve access to the best available information, services, and support relating to Jewish genetic disorders.
• To facilitate access to responsible and professional testing services for people at risk of passing on, those directly affected by, Jewish genetic disorders.
In establishing the activities of the charity, the directors have given due consideration to the Charity Commission's guidance regarding the provision of public benefit.
## **Achievements and Performance**
The support Jnetics offers the community has grown rapidly in recent years, with a commensurate increase in the support from the community. So, although incoming our resources declined in 2021 compared with 2020 due to the continuing impact of Covid 19, Jnetics drew on its reserves to strengthen its capabilities and financial controls to reflect the increased scale and scope of the organisation and expanded its fund-raising and profile-raising activities for the future.
During 2021 Jnetics' main areas of focus were the re-establishment of our ‘Jnetics in Schools’ campaign in mainstream Jewish secondary schools across the country, supporting the continued growth of 'the Jnetics Clinic’, and the delivery of our ‘Jnetics on Campus’ university programme. WE delivered Jnetics in Schools in two of the mainstream Jewish secondary schools in the country and laid the foundations for delivery to the remaining six by the end of the 2021/22 academic year. We educated over 155 Year 12 students and screened 76 of them. Jnetics on Campus, which was launched in 2020 in response to Covid 19, was repeated in 2021. Once again it was well received by both students and the many community stakeholders who supported its delivery, and 256 university students were screened across 56 educational centres in the UK.
We also continued to expand the outreach pre-marriage programme with increasing support from all synagogue movements, counselling young people approaching marriage and screening 218 participants at the Barnet Clinic. Overall, in 2021, across the three programmes, 551 individuals were screened despite the detrimental effect Covid 19 had on our Jnetics in Schools during the first 9 months of 2021.
Following 4 years of research and development, we increased the Jnetics testing panel for recessive disorders from nine to 47 disorders, including genetic disorders prevalent in the Sephardi and Mizrachi communities and further conditions prevalent in the Ashkenazi community. We also introduced a couples screening option, at a more attractive price point than individual screenings. The impact of both the larger panel and the couples screening has had a positive impact on the clinic, which has been virtually full to capacity since September 2021.
In 2021 we introduced a number of new fundraising channels, including a cycle challenge event and a patrons' dinner, all contributing to the growth and the financial stability of the charity.
## **Plans for Future Periods**
The first half of 2022 saw the launch of the charity’s first matched funding campaign, which exceeded our fundraising expectations and successfully introduced 2,500 new donors to Jnetics. It is a major step
4
Internal Use#
forward in helping Jnetics to improve the prevention and management of Jewish Genetic Disorders and to ensure that no further children are born into our community with any of the devestating recessive genetic conditions for which Jnetics tests.
A further significant event for Jnetics and the community was the announcement in June by NHS England of a proposed 3 year pilot screening programme for BRCA related and other hereditary cancers. This is likely to be available to anyone with one Jewish grandparent and will lead to long term improvements in cancer outcomes for the community. Jnetics had been looking at how better to support the community in relation to hereditary cancers and we were delighted to be approached by NHS England to support their programme. We already work closely with the NHS indelivering our recessive screening programme, and we will again work closely with the NHS to ensure the community's engagement with the new hereditary cancer screening programme. Nicole Gordon, our CEO, has been appointed to the NHS’s advisory group and we are collaborating with other community stakeholders to ensure a coordinated community response.
The second half of 2022 will see the introduction of a number of new awareness building and fund-raising events, including a lady’s lunch, Jnetics’ first Young Professionals’ event, and a series of scientific lectures which will enable us to further expand the charity’s reach. In addition, a dinner is planned for the end of 2022 to update key donors/stakeholders on the work that is being done with regards to hereditary cancers.
Looking further ahead, we see the need to continue to improve our delivery, efficiency and effectiveness so as to maintain and expand the support to the community that we provide across recessive disorders, hereditary cancers and, over time, other genetic disorders and issues. We will continue to build solid foundations for our future activities and see great potential for the community from our expanded recessive disorder panel and screening for hereditary cancers.
## **Financial review**
## **Principal sources of funding**
The charity receives most of its funding from donations and was able to claim gift aid where applicable.
## **Results for the year**
The financial statements for the year are set out in pages 8 to 15. The Statement of Financial Activities on page 8 reflects a deficit of £177,023 (2020 - surplus of £148,454) in the year.
## **Reserves**
The trustees aim to maintain free reserves sufficient to finance Jnetics operating costs for around 6 months. However, given the impact of COVID 19 and the developing success of the matched funding campaign the trustees felt confident in accepting a fall in reserves towards the year end in pursuit of the charity’s objectives. The reserves were more than replenished in January 2021. The charity's reserves at 31 December 2021 amounted to £66,727 (2020 - £243,750), of which £12,343 (2020 - £243,487) related to unrestricted funds and £57,209 (2020 - £231) to restricted funds.
## **Structure, governance and management**
## **Status of Charity and Governing Document**
Jnetics (""the charity"") is a company limited by guarantee (No.07087270) and a recognised English charity (No. 1134935), governed by its Memorandum and Articles of Association.
The charity was incorporated as Jewish Genetic Disorders UK on 25 November 2009 and changed its name to Jnetics on 2 July 2015.
## **Appointment of Directors**
5
Internal Use#
New Directors are nominated for appointment by the existing Directors. There is a three-year term for
Directorship subject to reappointment. Prior to and immediately after their appointment, new Directors are made familiar with the charity's values, its aims and objectives as well as its day-to-day operations, and as part of their induction, new Directors are required to understand their statutory responsibilities.
To replace retiring trustees, three new trustees were appointed by Jnetics in 2021. There is an ongoing programme to appoint new trustees as part of a process of improving Jnetic’s governance structure.
## **Statement on Risk**
The Directors assess the major risks to which the charity is exposed on an ongoing basis and establish procedures to mitigate those that are identified as a result of these review.
## **Office Bearers**
The Directors who served as trustees during the year and to the date of this report were as follows:
|AL Angel||
|---|---|
|L Birnbaum|(appointed 18 May 2022)|
|L Blitz|(appointed 1 June 2021)|
|N Goldschneider|(appointed 3 March 2021)|
|J Harris||
|E Kerr|(resigned 1 May 2021)|
|AM Leon|(appointed 21 October 2021)|
|IBP Pearl|(resigned 21 October 2021)|
|Dr TM Rothenberg|(resigned 1 May 2021)|
## **Statement of Directors' Responsibilities**
Company law requires the directors to prepare financial statements that give a true and fair view of the state of affairs of the charity and of its incoming resources and application of resources, including its surplus or deficit for that period. In doing so the directors are required to:
- select suitable accounting policies and then apply them consistently;
- make judgements and estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue its activities.
The directors are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the charity's financial position and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the fraud and other irregularities.
This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.
## **On behalf of the Board**
**AL Angel, Director and Chair**
**Date: 29 September 2022**
6
Internal Use#
## **Jnetics**
## **Independent Examiner's Report** _for the year ended 31 December 2021_
I report on the financial statements of the Trust for the period ended 31 December 2021, which are set out on pages 8 to 15.
## **Respective responsibilities of trustees and examiner**
The charity’s directors are responsible for the preparation of the financial statements. The charity’s directors consider that an audit is not required for this year under section 144(1)(a) of the Charities Act 2011 (the 2011 Act) and that an independent examination is needed.
It is my responsibility:
- to examine the accounts (under section 145 of the 2011 Act);
- to follow the procedures laid down in the General Directions given by the Charity Commission (under section 145(5)b of the 2011 Act); and
- to state whether particular matters have come to my attention.
## **Basis of Independent examiner’s report**
My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the financial statements presented with those records. It also includes consideration of any unusual items or disclosures in the financial statements, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the financial statements present a ‘true and fair view’ and the report is limited to those matters set out in the statement below.
## **Independent examiner’s statement**
In connection with my examination, no matter has come to my attention:
- (a) which gives me reasonable cause to believe that in any material respect the requirements (i) to keep accounting records in accordance with section 386 of the Companies Act 2006; and (ii) to prepare financial statements which accord with the accounting records and comply with the accounting requirements of section 396 of the Companies Act 2006 and with the methods and principles of the Statement of Recommended Practice: Accounting and Reporting by Charities.
have not been met; or
- (b) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the financial statements to be reached.
Emma Benjamin CA Independent Examiner 14 David Mews Oliver Clive & Co Limited London Chartered Accountants W1U 6EQ
Dated ......................
7
Internal Use#
## **Jnetics**
**Statement of Financial Activities** _for the year ended 31 December 2021_
|**Incoming Resources**
**Donations and legacies**
Voluntary income
**Other**
Government Grant
**Total Incoming Resources**
**Resources Expended**
Other
Expenditure on charitable activities
Expenditure on raising funds
**Total Resources Expended**
**Net income/(expenditure) for the year**
**Transfers between funds**
**Net movement in funds**
**Fund balance at 31 December 2020**
**Fund balance at 31 December 2021**|**Notes**|**£**
354,135
5,025
359,160
-
314,756
124,309
439,065
(79,905)
(151,239)
(231,144)
243,487
12,343
**Unrestricted**
**Funds**|**£**
-
-
-
2,857
-
-
2,857
(2,857)
-
(2,857)
32
(2,825)
**Designated**
**Funds**|**£**
103,000
-
103,000
-
141,412
55,849
197,261
(94,261)
151,239
56,978
231
57,209
**Restricted**
**Funds**|**Year**
**Ended**
**2021**
**Total**
**£**
457,135
5,025
462,160
2,857
456,168
180,159
639,183
(177,023)
-
(177,023)
243,750
66,727|**Year**
**Ended**
**2020**
**Total**
**£**
568,876
6,945|
|---|---|---|---|---|---|---|
||**6**
**7**
**8**
**9**
**10,11**||||||
|||||||575,821|
|||||||3,348
357,871
66,148|
|||||||427,367|
|||||||148,454
-
148,454
95,296|
|||||||243,750|
The statement of financial activities includes all gains and losses in the year and therefore a separate statement of total recognised gains and losses has not been prepared.
All of the incoming resources and resources expended derive from continuing activities.
The notes on pages 10 to 15 form part of these financial statements.
8
Internal Use#
## **Jnetics**
## **Statement of Financial Position as at** _31 December 2021_
|**Notes**
**Fixed Assets**
Tangible Fixed assets
**2**
**Current Assets**
Debtors
**4**
Cash at bank and in hand
**Creditors: Amounts falling due within**
**one year**
**5**
**Net current assets**
**Total Net Assets**
**Represented by**
Unrestricted funds
**10**
Designated Funds
**9**
Restricted funds
**9**
**Total Funds**|**£**
**£**
**£**
**£**
488
3,345
488
3,345
29,747
56,953
217,215
244,464
246,962
301,417
(180,723)
(61,012)
66,239
240,405
66,727
243,750
12,343
243,487
(2,825)
32
57,209
231
66,727
243,750
**2021**
**2020**|**£**
**£**
**£**
**£**
488
3,345
488
3,345
29,747
56,953
217,215
244,464
246,962
301,417
(180,723)
(61,012)
66,239
240,405
66,727
243,750
12,343
243,487
(2,825)
32
57,209
231
66,727
243,750
**2021**
**2020**|
|---|---|---|
||||
|||243,750|
|||243,487
32
231|
|||243,750|
The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.
## **The Directors acknowledge their responsibility for:**
(a) ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to the financial statements, so far as applicable to the company.
These accounts have been prepared in accordance with the provisions applicable to companies subject to small companies' regime.
The financial statements were approved by the Board on ………................... and signed on their behalf by: **29 September 2022**
AL Angel, Director
The notes on pages 10 to 15 form part of these financial statements.
9
Internal Use#
## **Jnetics**
## **Notes to the Financial Statements** _for the year ended 31 December 2021_
**1 Accounting Policies** The principal accounting policies are summarised below. The accounting policies have been applied consistently throughout the year and the preceding year. **1.1 Accounting convention** The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)', Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. **1.2 Prior period restated balances** In the financial statements for the year ended 31 December 2021, amounts included in creditors relating to deferred income on grants were not netted off against corresponding balances included within debtors. **1.2 Basis of accounting** The financial statements have been prepared under the historical cost convention. **1.3 Incoming Resources** All incoming resources are included in the statement of financial activities when the charity is entitled to the income and the amount can be quantified with reasonable accuracy. The following specific policies are applied to particular categories of income: All voluntary income and bank interest is accounted for when received. Tax recovered on Gift Aid is accounted for on an accruals basis. The value of services provided by volunteers has not been included. Grants are recognised in profit or loss on a systematic basis over the periods in which the entity recognises expenses for the related costs for which the grants are intended to compensate. **1.4 Resources Expended** All expenditure is recognised on an accruals basis. Expenditure includes any VAT which cannot be recovered and is included in the relevant costs in the statement of financial activities. Expenditure on raising funds comprise the cost of donations made; expenditure on charitable activities include costs incurred by the charity in delivery of its activities and services for its beneficiaries. Governance costs are those incurred in connection with the administration of the charity and compliance woth the constitutional and statutory requirements. **1.5 Fund Accounting** General funds are unrestricted funds which are available for use at the discretion of the Trustees in the furtherance of the general objectives of the charity and which have not been designated for other purposes. Restricted funds comprise grants and other income received for spending on specified purposes as laid down by the grantor. Designated funds represent the net book value of the Charity's assets. **1.6 Fixed assets** Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows: Computer Equipment 3 years straight line Furniture and Fittings 4 years straight line **1.7 Going Concern**
There are no material uncertainties about the charity's ability to continue and the Trustees are confident that the charity has adequate resources to continue its operations for the forseeable future. Accordingly, the accounts were prepared on a going concern basis.
10
Internal Use#
## **Jnetics**
## **Notes to the Financial Statements** _for the year ended 31 December 2021_
## **2 Fixed assets**
|**Furniture**
**Computer**
**and Fittings**
**Equipment**
**£**
**£**
**Cost**
Cost as at 31 December 2020
6,912
5,360
Additions
-
-
Disposals
-
-
Cost C/fwd at 31 December 2021
6,912
5,360
**Depreciation**
Accumulated depreciation at 31 December 2020
5,842
3,085
Depreciation Charge
1,070
1,787
Disposals
-
-
Accumulated depreciation at 31 December 2021
6,912
4,872
**Net book value at 31 December 2021**
**-**
**488**
**Net book value at 31 December 2020**
**1,070**
**2,275**
**3**
**Staff Costs**
**Year**
**Unrestricted**
**Funds**
**Restricted**
**Ended**
**General funds**
**Designated**
**funds**
**2021**
**£**
**£**
**£**
**£**
Gross salaries
126,707
-
56,927
183,634
Social security costs
10,574
-
4,751
15,325
Pension costs
2,891
-
1,299
4,190
**140,173**
**-**
**62,976**
**203,149**
Allocated as follows:
Charitable Activities - staff costs (Note 9)
203,149
Charitable Activities - governance costs (Note 9)
-
**203,149**|**Total**
**£**
12,272
-
-|
|---|---|
||12,272|
||8,927
2,857
-|
||11,784|
|||
||**488**|
|||
||**3,345**|
||**Year**
**Ended**
**2020**
**£**
159,272
11,532
3,631|
||**174,435**|
||174,435
-|
||**174,435**|
The average number of employees in the year, calculated on a full time equivalent basis, was 5 (2020: 4) No employees received remuneration of £60,000 or more. No remuneration was paid to directors during the period. No expenses were reimbursed to Trustees during the year.
## **4 Debtors**
|Trade Debtors
Gift Aid Debtor
Other grant debtors
Prepayments
Deposits|**Year**
**Ended**
**2021**
**£**
137
11,588
10,000
6,355
1,668
29,747|**Year**
**Ended**
**2020**
**£**
2,317
50,000
2,968
1,668|
|---|---|---|
|||56,953|
11
Internal Use#
## **Jnetics**
## **Notes to the Financial Statements** _for the year ended 31 December 2021_
|**5**|**Creditors**
Creditors due within 1 year
Accounts Payable
Accruals
Deferred income
Other creditors|**Year**
**Ended**
**2021**
**£**
65,386
92,592
17,562
5,184
180,723|**Year**
**Ended**
**2020**
**£**
-
6,562
50,000
4,450|
|---|---|---|---|
||||61,012|
Deferred income comprises grants that have been recognised in the period for which the grants are intended to compensate.
|**6**
**Voluntary income**
**Income from generated funds**
Donations
Grants
Gift Aid
Challenge/Events Income
Appeal Income
Patronage
Trust/Screening income
Government Grant
Tributes and Celebrations
Interest|**Year**
**Ended**
**2021**
**Unrestricted**
**Funds**
**Restricted**
**Total**
**General funds**
**Designated**
**funds**
**funds**
**£**
**£**
**£**
**£**
26,291
-
-
26,291
5,000
-
103,000
108,000
23,931
-
-
23,931
55,183
-
-
55,183
146,448
-
-
146,448
37,513
-
-
37,513
50,670
-
-
50,670
5,025
-
-
5,025
9,093
-
-
9,093
6
-
-
6
**359,160**
**-**
**103,000**
**462,160**|**Year**
**Ended**
**2020**
**Total**
**funds**
**£**
410,791
100,000
14,095
-
-
-
43,990
6,945
-
-|
|---|---|---|
|||**575,821**|
- **7 Other resources expended**
The amount paid in the year comprised of the following:
|Depreciation|**Year**
**Ended**
**2021**
**Unrestricted**
**Designated**
**Restricted**
**Total**
**funds**
**funds**
**funds**
**funds**
**£**
**£**
**£**
**£**
-
2,857
-
2,857
**-**
**2,857**
**-**
**2,857**|**Year**
**Ended**
**2020**
**Total**
**funds**
**£**
3,348|
|---|---|---|
|||**3,348**|
12
Internal Use#
## **Jnetics**
## **Notes to the Financial Statements** _for the year ended 31 December 2021_
## **8 Resources expended - Expenditure on charitable activities**
|**Year**
**Ended**
**2021**
**Unrestricted**
**Funds**
**Restricted**
**Total**
**General funds**
**Designated**
**funds**
**funds**
**£**
**£**
**£**
**£**
Salaries
126,707
-
56,927
183,633
Social security costs
10,574
-
4,751
15,325
Pension
2,891
-
1,299
4,190
Screening
129,123
-
58,012
187,135
Database
2,245
-
1,009
3,253
Insurance
881
-
396
1,277
Office costs
11,479
-
5,157
16,636
Telephone
929
-
418
1,347
Post
1,626
-
731
2,357
Sundry
1,463
-
657
2,121
Accountancy
14,907
-
6,698
21,605
Consultancy
9,372
-
4,211
13,583
Bank and Online Fees
1,845
-
829
2,674
Bad debts
-
-
-
-
Legal and Professional
624
-
280
905
Subscriptions
87
-
39
126
314,756
-
141,412
456,167
**Resources expended - Expenditure on raising funds**
**Year**
**Ended**
**2021**
**Unrestricted**
**Funds**
**Restricted**
**Total**
**General funds**
**Designated**
**funds**
**funds**
**£**
**£**
**£**
**£**
Website
2,820
-
1,267
4,087
Awareness
22,668
-
10,184
32,853
Meeting/Travel
257
-
115
372
Fundraising
33,144
-
14,891
48,035
Panel Expansion Costs
2,898
-
1,302
4,200
Genetic Counselling Costs
62,522
-
28,090
90,612
124,309
-
55,849
180,159
_Governance costs_
Salaries (Note 3)
-
-
-
-
Independent Examiner's fee
-
-
-
-
-
-
-
-
Total resources
expended
**439,065**
**2,857**
**197,261**
**639,182**|**Year**
**Ended**
**2020**
**Total**
**funds**
**£**
159,272
11,532
3,631
124,516
3,005
1,267
20,930
2,249
5,543
1,812
4,224
14,990
2,304
2,595
-
-|
|---|---|
||357,870|
||**Year**
**Ended**
**2020**
**Total**
**funds**
**£**
2,455
33,488
507
29,698
-
-|
||66,148|
||-
-|
||-|
|||
||**427,366**|
- **9 Resources expended - Expenditure on raising funds**
13
Internal Use#
## **Jnetics**
## **Notes to the Financial Statements** _for the year ended 31 December 2021_
## **10 Statement of restricted funds**
|Movement of restricted funds in current year:
BRCA Project
GENEius
Movement of restricted funds in prior year:
BRCA Project
GENEius|**31-Dec**
**Incoming**
**Resources**
**Transfers between**
**31-Dec**
**2020**
**Resources**
**Expended**
**Funds**
**2021**
**£**
**£**
**£**
**£**
**£**
57,209
-
-
-
57,209
(56,978)
103,000
(197,261)
151,239
-|
|---|---|
||**231**
**103,000**
**(197,261)**
**151,239**
**57,209**|
||**31-Dec**
**Incoming**
**Resources**
**Transfers between**
**31-Dec**
**2019**
**Resources**
**Expended**
**Funds**
**2020**
**£**
**£**
**£**
**£**
**£**
57,209
-
-
-
57,209
26,533
-
101,000
(131,445)
-
(56,978)|
||**30,676**
**101,000**
**(131,445)**
**-**
**231**|
## Explanation of funds:
BRCA Project: To fund a project to develop key information resources and raise awareness relating to BRCA associated cancers particularly among the 'at increased risk' Ashkenazi Jewish population in the UK with the aim of improving the awareness, diagnosis and management of these cancers.
GENEius: Education and screening initiative that focuses on young Jewish adults. By strategically targeting the parents of the future, it aims to entirely eliminate severe recessive Jewish genetic disorders (JGDs) from the UK Jewish community.
## **11 Statement of unrestricted funds**
|Movement of unrestricted funds in current year:|Movement of unrestricted funds in current year:||||||
|---|---|---|---|---|---|---|
||**31-Dec**|**Incoming**||**Resources**|**Transfers between**|**31-Dec**|
||**2020**|**Resources**|**Transfers**|**Expended**|**Funds**|**2021**|
|||**£**|**£**|**£**|**£**|**£**|
|General Fund|243,487|359,160|-|(439,065)|(151,239)|12,343|
|Designated Assets Fund|32|-|-|(2,857)|-|(2,825)|
||**243,519**|**359,160**|**-**|**(441,922)**|**(151,239)**|**9,518**|
|Movement of unrestricted funds in prior year:|||||||
||**31-Dec**|**Incoming**||**Resources**|**Transfers between**|**31-Dec**|
||**2019**|**Resources**|**Transfers**|**Expended**|**Funds**|**2020**|
|||**£**|**£**|**£**|**£**|**£**|
|General Fund|61,341|475,821|(1,100)|(292,574)|-|243,487|
|Designated Assets Fund|3,280|-|100|(3,348)|-|32|
||**64,621**|**475,821**|**(1,000)**|**(295,922)**|**-**|**243,519**|
Explanation of funds:
General Fund: This fund is used for the furtherance of the objects of the charity. Designated Assets Fund: This fund represents the net book value of the Charity's assets.
14
Internal Use#
## **Jnetics**
## **Notes to the Financial Statements** _for the year ended 31 December 2021_
## **12 Net Asset by Fund**
|**Net Asset by Fund**||
|---|---|
|Fixed Assets
Current Assets
Debtors
Cash at bank and in hand
Creditors < 1 year
Creditors
Net Assets|**Year**
**Year**
**Ended**
**Ended**
**2021**
**2020**
**Unrestricted**
**Funds**
**Restricted**
**Total**
**Total**
**General funds**
**Designated**
**funds**
**funds**
**funds**
**£**
**£**
**£**
**£**
**£**
-
488
-
488
3,345
29,747
-
-
29,747
56,953
163,319
(3,313)
57,209
217,215
244,465
(180,723)
-
-
(180,723)
(61,012)|
||12,343
(2,825)
57,209
66,727
243,751|
## **13 Related Party Transactions**
The Directors, together with a Foundation related to the Directors, made donations without conditions attached totalling £23,260 during the year (2020: £48,548).
## **14 Taxation**
No liability to UK Corporation Tax arises in light of the company's charitable status.
## **15 Liability of Members**
The company is limited by guarantee and has no share capital. The liability of each member in the event of winding-up is limited to £1.
## **16 Operating lease commitments**
As at 31 December 2021 the charity had financial commitments in respect of operating leases totalling _£Nil (2020: £Nil)_ .
## **16 Events after the reporting date**
The outbreak of COVID-19 at the end of 2019 was followed by a nationwide lockdown order by the government on 23 March 2020 which resulted in business closures across the country. This will have an impact on income. However, the charity continues to generate income and the Trustees regularly review the impact of lockdowns and closures. A reliable estimate of the impact on income could not be made.
15